| Adventist Health Clear Lake | |
|
6300 E. Highway 20 Lucerne CA 95458 | |
| (707) 274-9299 | |
| Not Available |
| Full Name | Adventist Health Clear Lake |
|---|---|
| Speciality | Clinic/Center |
| Location | 6300 E. Highway 20, Lucerne, California |
| Authorized Official Name and Position | Colleen Assavapisitkul (PRESIDENT) |
| Authorized Official Contact | 7079955827 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Adventist Health Clear Lake Po Box 888837 Los Angeles CA 90088-8837 Ph: () - | Adventist Health Clear Lake 6300 E. Highway 20 Lucerne CA 95458 Ph: (707) 274-9299 |
| NPI Number | 1093274508 |
|---|---|
| Provider Enumeration Date | 03/14/2019 |
| Last Update Date | 12/20/2022 |
| Medicare PECOS PAC ID | 3072421197 |
|---|---|
| Medicare Enrollment ID | O20190726002811 |
News Archive
Novartis announced today positive results of the first pivotal Phase III trial of ACZ885 in patients with systemic juvenile idiopathic arthritis (SJIA), a rare and serious childhood auto-inflammatory disease. The results, presented at the 2011 European Pediatric Rheumatology Congress in Bruges, Belgium, showed all primary and secondary endpoints of the study were met.
A recent study by researchers in France has compared the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern. The team found a significant transmission advantage of V2 (from lineage B.1.351) over V1 (from lineage B.1.1.7). A pre-print version of the research paper is available on the medRxiv* server.
Sirolimus, whether given at the time of liver transplantation or after, is associated with poorer outcomes in patients with hepatitis C virus infection compared with those who do not take the immunosuppressant, shows a US study.
The American Society of Transplantation (AST) presents Transplantation: The Year in Review, Oct. 24-25, 2009 in Houston, Texas. The meeting features a review of the most recent developments in the field of organ transplantation from May 2008 up to and including the 2009 American Transplant Congress (ATC) that was held in May in Boston.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093274508 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QR1300X | Clinic/center - Rural Health | (* (Not Available)) | Primary |
News Archive
Novartis announced today positive results of the first pivotal Phase III trial of ACZ885 in patients with systemic juvenile idiopathic arthritis (SJIA), a rare and serious childhood auto-inflammatory disease. The results, presented at the 2011 European Pediatric Rheumatology Congress in Bruges, Belgium, showed all primary and secondary endpoints of the study were met.
A recent study by researchers in France has compared the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern. The team found a significant transmission advantage of V2 (from lineage B.1.351) over V1 (from lineage B.1.1.7). A pre-print version of the research paper is available on the medRxiv* server.
Sirolimus, whether given at the time of liver transplantation or after, is associated with poorer outcomes in patients with hepatitis C virus infection compared with those who do not take the immunosuppressant, shows a US study.
The American Society of Transplantation (AST) presents Transplantation: The Year in Review, Oct. 24-25, 2009 in Houston, Texas. The meeting features a review of the most recent developments in the field of organ transplantation from May 2008 up to and including the 2009 American Transplant Congress (ATC) that was held in May in Boston.
› Verified 7 days ago
Lucerne Community Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 6300 E. Hwy 20, Lucerne, CA 95458 Phone: 707-274-9299 Fax: 707-274-9297 |